de Lange Syndrome Clinical Presentation

  • Author: Krystyna H Chrzanowska, MD, PhD; Chief Editor: Dirk M Elston, MD   more...
 
Updated: Jan 25, 2012
 

History

The patient history in Cornelia de Lange syndrome (CDLS) may reveal clues to the diagnosis, such as the following:

  • The course of pregnancy and delivery offer clues. Preterm delivery is noted in approximately 30% cases.
  • Retardation of growth is often profound and of prenatal onset.[35, 37, 38]
  • The difficulties in weight and height gain persist in the postnatal period as a result of feeding difficulties
  • Sucking and swallowing problems and an inability to take an appropriate amount of food for age in the first months of life result in failure to thrive.
  • Recurrent respiratory tract infections, hyperactivity, nocturnal agitation, and behavioral problems may be atypical manifestations of gastroesophageal reflux (GER).
  • A diminished responsiveness to pain has been reported and was found to be associated both with mental retardation and with autism; it might contribute to self-injury behaviors.
  • Psychomotor development and behavioral findings are as follows:
    • Most affected individuals with the classic phenotype have moderate-to-profound mental retardation.[35]
    • Borderline-to-mild deficiency is usually observed in patients who are mildly affected; near-normal intelligence has occasionally been recorded.[30, 35, 39]
    • The cognitive profile is characterized by delayed verbal communication with specific deficits in expressive language; receptive language and verbal comprehension are less affected. Visuospatial memory and perceptual organization are usually normal.
    • The behavioral manifestations include a wide spectrum of symptoms, such as sleep disturbances, daily aggression and hyperactivity, poor relationship abilities, stereotyped behavior, autism, and self-injury.[35, 40, 41, 42, 43]
Next

Physical

Cornelia de Lange syndrome (CDLS) is a highly variable multiple congenital anomaly/mental retardation (MCA/MR) syndrome, ranging from perinatal lethality with multiple malformations, including severe upper limb deficiency, to a degree of mildness compatible with reproduction and near-normal intellect. Diagnosis is based on the characteristic phenotype, in particular a striking facial gestalt, prenatal and postnatal growth retardation, various skeletal abnormalities, hypertrichosis, and developmental delay.[26, 34, 35, 44]

The phenotypic dichotomy, classic and mild cases, is now well established. The prognosis for patients with the mild phenotype is much better than that for patients with the classic form.[26, 34, 36, 45] A diagnostic scoring system for severity in CDLS has been proposed.[37]

  • The following is a classification system based on the clinical variability in CDLS:
    • Patients with CDLS type I (classic) have the characteristic facial and skeletal changes, a prenatal growth deficiency that is progressive postnatally, moderate-to-profound psychomotor retardation, and major malformations resulting in severe disability or death.
    • Patients with CDLS type II (mild) have facial and minor skeletal abnormalities similar to those seen in type I; however, they are distinguished by less severe psychomotor retardation and milder growth deficiency. The prognosis is more optimistic, but, paradoxically, behavior dysfunction may be more evident.
  • The following craniofacial characteristics are unique and of great diagnostic value:
    • Microbrachycephaly: The average head circumference remains less than the second percentile throughout life.
    • Low frontal hairline
    • Well-defined, arched "pencilled" eyebrows
    • Synophrys
    • Long, curly eyelashes
    • Short nose with anteverted nares
    • Triangular nasal tip
    • Long philtrum
    • Crescent-shaped mouth
    • Thin lips
    • Widely spaced (late-erupting) teeth
    • Micrognathia
    • Low-set and posteriorly rotated ears
    • See the images below.Case study 1 of classic de Lange phenotype is showCase study 1 of classic de Lange phenotype is shown (same patient as in Images 2-6). Facial characteristics of a 10-month-old girl are pictured. Note well-defined eyebrows with synophrys, depressed nasal bridge, and long smooth philtrum. Case study 1 (same patient as in Images 1 and 3-6)Case study 1 (same patient as in Images 1 and 3-6). Lateral facial profile is pictured. The eyebrows are neat, arched, and well defined. The nasal bridge is depressed, and the nares are upturned. Case study 1 (same patient as in Images 1-2 and 4-Case study 1 (same patient as in Images 1-2 and 4-6). The patient, aged 5 years, is shown; note microbrachycephaly, well-defined eyebrows, anteverted nares, long and thin upper lip, down-turned angles of mouth, and widely spaced teeth. Case study 1 (same patient as in Images 1-3 and 5-Case study 1 (same patient as in Images 1-3 and 5-6). Upper limb reduction anomalies are pictured with only 2 fingers present. Case study 1 (same patient as in Images 1-4 and 6)Case study 1 (same patient as in Images 1-4 and 6). Note short hypoplastic fifth finger. Case study 1 (same patient as in Images 1-5). SmalCase study 1 (same patient as in Images 1-5). Small feet with short hypoplastic toes and syndactyly of the second and third toes is pictured.
  • Retardation of growth, often of prenatal onset, is one diagnostic criterion for CDLS that can also help to discriminate classic cases from mild cases.[38, 45, 46]
    • Profound prenatal growth deficiency (>2.5 standard deviations below the mean for gestation) becomes more severe postnatally (>3.5 standard deviations below the mean) and is characteristic for classic (type I) CDLS.
    • Birth weight greater than 2500 g and less marked postnatal growth deficiency may help to classify a patient as having mild (type II) CDLS.
    • Growth persists below the normal curves in most of the patients throughout life.
    • Height velocity is equal to the reference range, and weight velocity is below the reference range throughout life until adolescence.
  • Skeletal abnormalities characteristic for classic CDLS include major longitudinal reduction abnormalities of the upper limbs, including hypoplastic or absent ulnas and/or oligodactyly (which, if bilateral, can be asymmetric). This abnormality is not observed in persons with mild CDLS.[26, 45]
    • Severe malformations of the lower limbs are less common than upper limb anomalies.
    • Most patients have relatively small hands, feet, or both.
    • Limitation of extension at the elbows with accompanying radiological characteristics may help with the diagnosis because they are not frequently observed.
    • Other minor variable anomalies, such as clinodactyly, single palmar crease, proximal placement of the thumb(s), and syndactyly of toes 2 and 3 are frequently observed in many other syndromes or in healthy individuals; therefore, they are of limited diagnostic aid.
  • Common cutaneous manifestations include hypertrichosis in the form of synophrys, long eyelashes, and hirsutism on the back.[26, 34]
    • Cutis marmorata is noted in CDLS patients.
    • Hypoplastic nipples and umbilicus are observed most commonly in persons with the classic type and are observed less frequently in those with the mild phenotype.
    • Multiple capillary or cavernous hemangiomas are occasionally reported; these hemangiomas may cause the observed thrombocytopenia that is reported, most likely occurring as a result of a slow, consumptive coagulopathy.[33, 47, 48, 49]
    • Multiple pigmented nevi were observed incidentally.[50]
    • Ulerythema ophryogenes was reported in a 17-year-old girl with Brachmann-de Lange syndrome (BDLS).[51]
    • See the images below.Case study 2 of mild de Lange syndrome is shown (sCase study 2 of mild de Lange syndrome is shown (same patient as in Images 8-10). The face of a 1.5-year-old girl is pictured. Note neat eyebrows with delicate synophrys, long eyelashes, depressed nasal bridge, upturned nares, long philtrum, thin upper lip, and small chin. Case study 2 (same patient as in Images 7 and 9-10Case study 2 (same patient as in Images 7 and 9-10). Lateral facial profile shows depressed nasal bridge, thin upper lip, and small mandible. Case study 2 (same patient as in Images 7-8 and 10Case study 2 (same patient as in Images 7-8 and 10). The patient, aged 8 years, is shown; note delicate synophrys of the eyebrows, upturned nares, long philtrum, and thin upper lip. Case study 2 (same patient as in Images 7-9). LateCase study 2 (same patient as in Images 7-9). Lateral facial profile of the patient, aged 8 years, is shown.
  • GI problems occur with high frequency, and they contribute to feeding difficulties and failure to thrive.[26, 52, 53, 54]
    • Pyloric stenosis is the most frequent cause of persistent vomiting in the newborn period.
    • GER and its sequelae are thought to be the most underappreciated medical problems in persons with BDLS. Approximately two thirds of children are first seen with clinical signs that might be referred to this area.[55, 54, 56]
    • Pathological GER was found in 65% individuals. Silent GER can cause esophageal damage and symptoms of pulmonary congestion and irritation due to chemical pneumonitis.[26, 53, 54]
    • The most severe complications of GER include Barrett esophagus and the Sandifer complex, which is characterized by torticollis, opisthotonus, and paroxysmal dystonic posture.[35, 56, 57]
    • Two other GI-related problems are intestinal malrotation with volvulus[58] and congenital diaphragmatic hernia.[59, 60] The latter anomaly might be more common than initially realized.
    • Omphalocele was reported in one patient.[61]
  • Cardiovascular problems in the form of congenital heart malformations are diagnosed in approximately 14% of children. Most common are ventricular and atrial septal defects, pulmonic stenosis, and tetralogy of Fallot; various other anomalies occasionally occur.[26]
  • Most respiratory problems are probably initiated and/or complicated by undetected GER:
    • Upper respiratory tract infections and pneumonias are reported in 25% of individuals.
    • Severe complications due to bronchopulmonary dysplasia have also been described.
    • Choanal atresia was diagnosed at birth in 3 children.
  • Hearing problems occur frequently.[26]
    • Hearing deficits from mild to severe may be present in 60-100% of all CDLS patients.
    • Stenosis of the external auditory canals is found in 80% of examined children.
  • Ophthalmologic problems occur in a high proportion of children with CDLS.[35, 62, 63, 64]
    • Myopia was reported in 60% of patients, ptosis in 45%, nystagmus in 37%, microcornea in 21%, and nasolacrimal duct obstruction in 16%.
    • Chronic blepharitis is a frequent complication.
    • Glasses are poorly tolerated.
  • Other problems are variable and include the following:
    • Urinary tract anomalies are common and include hydronephrosis, urethral reflux, subcortical renal cysts, and renal dysplasia or hypoplasia.[10, 65]
    • Male hypogonadism and cryptorchidism are present in more than half the boys.[26, 55]
    • Seizures are reported in 23-26% of individuals.[26, 35, 66]
    • Heat intolerance and absence of pain sensation have been observed in several patients.[26]
    • One described patient had rosacea, most likely an incidental finding.[67]
Previous
Next

Causes

Single-allele mutations at the NIPBL locus account for approximately 50-55% of affected individuals, and mutations in SMC1A locus for a further 5% of Cornelia de Lange syndrome (CDLS) cases. For details, see Pathophysiology.

  • Most cases are sporadic (>99% of mutations occur de novo), but familial occurrence and parental consanguinity have been recorded (< 1%).
  • When parents are not affected, the risk of recurrence has been estimated at 1.5%; germinal mosaicism can be an explanation for unaffected parents having more than one affected child.[26]
  • Numerous chromosomal rearrangements have been reported in patients with CDLS or a CDLS-like phenotype. Some of these rearrangements may be causative of a disease phenotype.

Genotype-phenotype correlations were analyzed in several cohorts of patients.[4, 6, 9, 10, 11, 35] In general, mutation-positive patients were found to be more severely affected in comparison to mutation-negative patients, and a trend toward a milder phenotype is observed in persons with missense mutations in the NIPBL gene compared with those with truncating mutations.

Previous
Proceed to Differential Diagnoses
 
 
Contributor Information and Disclosures
Author

Krystyna H Chrzanowska, MD, PhD  Head of Genetic Counseling Unit, Associate Professor, Department of Medical Genetics, Children's Memorial Health Institute, Warsaw, Poland

Disclosure: Nothing to disclose.

Coauthor(s)

Camila K Janniger, MD  Clinical Professor of Dermatology, Clinical Associate Professor of Pediatrics, Chief of Pediatric Dermatology, University of Medicine and Dentistry of New Jersey-New Jersey Medical School

Camila K Janniger, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Specialty Editor Board

Albert C Yan, MD  Section Chief, Associate Professor, Department of Pediatrics, Section of Dermatology, Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine

Albert C Yan, MD is a member of the following medical societies: American Academy of Dermatology, American Academy of Pediatrics, Society for Investigative Dermatology, and Society for Pediatric Dermatology

Disclosure: Nothing to disclose.

David F Butler, MD  Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic

David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Robert A Schwartz, MD, MPH  Professor and Head, Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, University of Medicine and Dentistry of New Jersey-New Jersey Medical School

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi

Disclosure: Nothing to disclose.

Catherine M Quirk, MD  Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania

Catherine M Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology

Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD  Director, Ackerman Academy of Dermatopathology, New York

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Additional Contributors

The authors and editors of eMedicine gratefully acknowledge the contributions of previous Chief Editor, William D. James, MD, to the development and writing of this article.

References

  1. McNairn AJ, Gerton JL. Cohesinopathies: One ring, many obligations. Mutat Res. Dec 1 2008;647(1-2):103-11. [Medline].

  2. Strachan T. Cornelia de Lange Syndrome and the link between chromosomal function, DNA repair and developmental gene regulation. Curr Opin Genet Dev. Jun 2005;15(3):258-64. [Medline].

  3. Krantz ID, McCallum J, DeScipio C, et al. Cornelia de Lange syndrome is caused by mutations in NIPBL, the human homolog of Drosophila melanogaster Nipped-B. Nat Genet. Jun 2004;36(6):631-5. [Medline].

  4. Tonkin ET, Smith M, Eichhorn P, et al. A giant novel gene undergoing extensive alternative splicing is severed by a Cornelia de Lange-associated translocation breakpoint at 3q26.3. Hum Genet. Jul 2004;115(2):139-48. [Medline].

  5. Borck G, Zarhrate M, Bonnefont JP, etal. Incidence and clinical features of X-linked Cornelia de Lange syndrome due to SMC1L1 mutations. Hum Mutat. Feb 2007;28(2):205-6. [Medline].

  6. Bhuiyan ZA, Klein M, Hammond P, et al. Genotype-phenotype correlations of 39 patients with Cornelia De Lange syndrome: the Dutch experience. J Med Genet. Jul 2006;43(7):568-75. [Medline].

  7. Gillis LA, McCallum J, Kaur M, et al. NIPBL mutational analysis in 120 individuals with Cornelia de Lange syndrome and evaluation of genotype-phenotype correlations. Am J Hum Genet. Oct 2004;75(4):610-23. [Medline].

  8. Miyake N, Visser R, Kinoshita A, et al. Four novel NIPBL mutations in Japanese patients with Cornelia de Lange syndrome. Am J Med Genet A. May 15 2005;135(1):103-5. [Medline].

  9. Schoumans J, Wincent J, Barbaro M, et al. Comprehensive mutational analysis of a cohort of Swedish Cornelia de Lange syndrome patients. Eur J Hum Genet. Feb 2007;15(2):143-9. [Medline].

  10. Selicorni A, Russo S, Gervasini C, et al. Clinical score of 62 Italian patients with Cornelia de Lange syndrome and correlations with the presence and type of NIPBL mutation. Clin Genet. Aug 2007;72(2):98-108. [Medline].

  11. Yan J, Saifi GM, Wierzba TH, et al. Mutational and genotype-phenotype correlation analyses in 28 Polish patients with Cornelia de Lange syndrome. Am J Med Genet A. Jul 15 2006;140(14):1531-41. [Medline].

  12. Braunholz D, Hullings M, Gil-Rodríguez MC, Fincher CT, Mallozzi MB, Loy E, et al. Isolated NIBPL missense mutations that cause Cornelia de Lange syndrome alter MAU2 interaction. Eur J Hum Genet. Sep 21 2011;[Medline].

  13. Bhuiyan ZA, Stewart H, Redeker EJ, et al. Large genomic rearrangements in NIPBL are infrequent in Cornelia de Lange syndrome. Eur J Hum Genet. Apr 2007;15(4):505-8. [Medline].

  14. Musio A, Selicorni A, Focarelli ML, et al. X-linked Cornelia de Lange syndrome owing to SMC1L1 mutations. Nat Genet. May 2006;38(5):528-30. [Medline].

  15. Borck G, Redon R, Sanlaville D, et al. NIPBL mutations and genetic heterogeneity in Cornelia de Lange syndrome. J Med Genet. Dec 2004;41(12):e128. [Medline].

  16. Deardorff MA, Kaur M, Yaeger D, et al. Mutations in cohesin complex members SMC3 and SMC1A cause a mild variant of cornelia de Lange syndrome with predominant mental retardation. Am J Hum Genet. Mar 2007;80(3):485-94. [Medline].

  17. Hoppman-Chaney N, Jang JS, Jen J, Babovic-Vuksanovic D, Hodge JC. In-frame multi-exon deletion of SMC1A in a severely affected female with Cornelia de Lange Syndrome. Am J Med Genet A. Nov 21 2011;[Medline].

  18. Baynam G, Goldblatt J, Walpole I. Deletion of 8p23.1 with features of Cornelia de Lange syndrome and congenital diaphragmatic hernia and a review of deletions of 8p23.1 to 8pter? A further locus for Cornelia de Lange syndrome. Am J Med Genet A. Jun 15 2008;146A(12):1565-70. [Medline].

  19. DeScipio C, Kaur M, Yaeger D, et al. Chromosome rearrangements in cornelia de Lange syndrome (CdLS): report of a der(3)t(3;12)(p25.3;p13.3) in two half sibs with features of CdLS and review of reported CdLS cases with chromosome rearrangements. Am J Med Genet A. Sep 1 2005;137(3):276-82. [Medline].

  20. Fryns JP. Partial trisomy 4p and Brachmann-de Lange syndrome. Am J Med Genet. Dec 11 2000;95(4):406. [Medline].

  21. Hulinsky R, Byrne JL, Lowichik A, Viskochil DH. Fetus with interstitial del(5)(p13.1p14.2) diagnosed postnatally with Cornelia de Lange syndrome. Am J Med Genet A. Sep 1 2005;137(3):336-8. [Medline].

  22. Price N, Bahra M, Griffin D, et al. Cornelia de Lange Syndrome in association with a balanced reciprocal translocation involving chromosomes 3 and 5. Prenat Diagn. Jul 2005;25(7):602-3. [Medline].

  23. Ireland M, English C, Cross I, et al. Partial trisomy 3q and the mild Cornelia de Lange syndrome phenotype. J Med Genet. Oct 1995;32(10):837-8. [Medline].

  24. McConnell V, Brown T, Morrison PJ. An Irish three-generation family of Cornelia de Lange syndrome displaying autosomal dominant inheritance. Clin Dysmorphol. Oct 2003;12(4):241-4. [Medline].

  25. Russell KL, Ming JE, Patel K, et al. Dominant paternal transmission of Cornelia de Lange syndrome: a new case and review of 25 previously reported familial recurrences. Am J Med Genet. Dec 15 2001;104(4):267-76. [Medline].

  26. Jackson L, Kline AD, Barr MA, Koch S. de Lange syndrome: a clinical review of 310 individuals. Am J Med Genet. Nov 15 1993;47(7):940-6. [Medline].

  27. Krajewska-Walasek M, Chrzanowska K, Tylki-Szymanska A, et al. A further report of Brachmann-de Lange syndrome in two sibs with normal parents. Clin Genet. Jun 1995;47(6):324-7. [Medline].

  28. Niu DM, Huang JY, Li HY, et al. Paternal gonadal mosaicism of NIPBL mutation in a father of siblings with Cornelia de Lange syndrome. Prenat Diagn. Nov 2006;26(11):1054-7. [Medline].

  29. Beck B, Fenger K. Mortality, pathological findings and causes of death in the de Lange syndrome. Acta Paediatr Scand. Sep 1985;74(5):765-9. [Medline].

  30. Opitz JM. The Brachmann-de Lange syndrome. Am J Med Genet. Sep 1985;22(1):89-102. [Medline].

  31. Barisic I, Tokic V, Loane M, et al. Descriptive epidemiology of Cornelia de Lange syndrome in Europe. Am J Med Genet A. Jan 1 2008;146A(1):51-9. [Medline].

  32. Schrier SA, Sherer I, Deardorff MA, Clark D, Audette L, Gillis L, et al. Causes of death and autopsy findings in a large study cohort of individuals with Cornelia de Lange syndrome and review of the literature. Am J Med Genet A. Dec 2011;155A(12):3007-24. [Medline]. [Full Text].

  33. Greenberg F, Robinson LK. Mild Brachmann-de Lange syndrome: changes of phenotype with age. Am J Med Genet. Jan 1989;32(1):90-2. [Medline].

  34. Ireland M, Burn J. Cornelia de Lange syndrome--photo essay. Clin Dysmorphol. Apr 1993;2(2):151-60. [Medline].

  35. Kline AD, Grados M, Sponseller P, et al. Natural history of aging in Cornelia de Lange syndrome. Am J Med Genet C Semin Med Genet. Aug 15 2007;145C(3):248-60. [Medline].

  36. Allanson JE, Hennekam RC, Ireland M. De Lange syndrome: subjective and objective comparison of the classical and mild phenotypes. J Med Genet. Aug 1997;34(8):645-50. [Medline].

  37. Kline AD, Krantz ID, Sommer A, et al. Cornelia de Lange syndrome: clinical review, diagnostic and scoring systems, and anticipatory guidance. Am J Med Genet A. Jun 15 2007;143A(12):11287-96. [Medline].

  38. Kousseff BG, Thomson-Meares J, Newkirk P, Root AW. Physical growth in Brachmann-de Lange syndrome. Am J Med Genet. Nov 15 1993;47(7):1050-2. [Medline].

  39. Saal HM, Samango-Sprouse CA, Rodnan LA, et al. Brachmann-de Lange syndrome with normal IQ. Am J Med Genet. Nov 15 1993;47(7):995-8. [Medline].

  40. Berney TP, Ireland M, Burn J. Behavioural phenotype of Cornelia de Lange syndrome. Arch Dis Child. Oct 1999;81(4):333-6. [Medline].

  41. Hyman P, Oliver C. Causal explanations, concern and optimism regarding self-injurious behaviour displayed by individuals with Cornelia de Lange syndrome: the parents' perspective. J Intellect Disabil Res. Aug 2001;45(Pt 4):326-34. [Medline].

  42. Moss J, Oliver C, Hall S, et al. The association between environmental events and self-injurious behaviour in Cornelia de Lange syndrome. J Intellect Disabil Res. Apr 2005;49(Pt 4):269-77. [Medline].

  43. Stavinoha RC, Kline AD, Levy HP, Kimball A, Mettel TL, Ishman SL. Characterization of sleep disturbance in Cornelia de Lange Syndrome. Int J Pediatr Otorhinolaryngol. Feb 2011;75(2):215-8. [Medline].

  44. Preus M, Rex AP. Definition and diagnosis of the Brachmann-De Lange syndrome. Am J Med Genet. Nov 1983;16(3):301-12. [Medline].

  45. Van Allen MI, Filippi G, Siegel-Bartelt J, et al. Clinical variability within Brachmann-de Lange syndrome: a proposed classification system. Am J Med Genet. Nov 15 1993;47(7):947-58. [Medline].

  46. Kline AD, Barr M, Jackson LG. Growth manifestations in the Brachmann-de Lange syndrome. Am J Med Genet. Nov 15 1993;47(7):1042-9. [Medline].

  47. Froster UG, Gortner L. Thrombocytopenia in the Brachmann-de Lange syndrome. Am J Med Genet. Jul 1 1993;46(6):730-1. [Medline].

  48. Fryns JP, Vinken L. Thrombocytopenia in the Brachmann-de Lange syndrome. Am J Med Genet. Feb 1 1994;49(3):360. [Medline].

  49. Lambert MP, Jackson LG, Clark D, Kaur M, Krantz ID, Deardorff MA. The incidence of thrombocytopenia in children with Cornelia de Lange syndrome. Am J Med Genet A. Jan 2011;155A(1):33-7. [Medline]. [Full Text].

  50. Filippi G. The de Lange syndrome. Report of 15 cases. Clin Genet. May 1989;35(5):343-63. [Medline].

  51. Florez A, Fernandez-Redondo V, Toribio J, Toribio J. Ulerythema ophryogenes in Cornelia de Lange syndrome. Pediatr Dermatol. Jan-Feb 2002;19(1):42-5. [Medline].

  52. Bull MJ, Fitzgerald JF, Heifetz SA, Brei TJ. Gastrointestinal abnormalities: a significant cause of feeding difficulties and failure to thrive in Brachmann-de Lange syndrome. Am J Med Genet. Nov 15 1993;47(7):1029-34. [Medline].

  53. Luzzani S, Macchini F, Valade A, et al. Gastroesophageal reflux and Cornelia de Lange syndrome: typical and atypical symptoms. Am J Med Genet A. 2003;119(3):283-7. [Medline].

  54. Rosenbach Y, Zahavi I, Dinari G. Gastroesophageal dysfunction in Brachmann-de Lange syndrome. Am J Med Genet. Feb 1 1992;42(3):379-80. [Medline].

  55. Hawley PP, Jackson LG, Kurnit DM. Sixty-four patients with Brachmann-de Lange syndrome: a survey. Am J Med Genet. Mar 1985;20(3):453-9. [Medline].

  56. Sommer A. Occurrence of the Sandifer complex in the Brachmann-de Lange syndrome. Am J Med Genet. Nov 15 1993;47(7):1026-8. [Medline].

  57. Pei RS, Lin CC, Mak SC, et al. Barrett's esophagus in a child with de Lange syndrome: report of one case. Acta Paediatr Taiwan. May-Jun 2000;41(3):155-7. [Medline].

  58. Masumoto K, Izaki T, Arima T. Cornelia de Lange syndrome associated with cecal volvulus: report of a case. Acta Paediatr. Jun 2001;90(6):701-3. [Medline].

  59. Cunniff C, Curry CJ, Carey JC, et al. Congenital diaphragmatic hernia in the Brachmann-de Lange syndrome. Am J Med Genet. Nov 15 1993;47(7):1018-21. [Medline].

  60. Marino T, Wheeler PG, Simpson LL, et al. Fetal diaphragmatic hernia and upper limb anomalies suggest Brachmann-de Lange syndrome. Prenat Diagn. Feb 2002;22(2):144-7. [Medline].

  61. Lemire EG. Omphalocele in an infant with Cornelia de Lange syndrome. Clin Dysmorphol. Oct 2006;15(4):255-6. [Medline].

  62. Levin AV, Seidman DJ, Nelson LB, Jackson LG. Ophthalmologic findings in the Cornelia de Lange syndrome. J Pediatr Ophthalmol Strabismus. Mar-Apr 1990;27(2):94-102. [Medline].

  63. Nallasamy S, Kherani F, Yaeger D, et al. Ophthalmologic findings in Cornelia de Lange syndrome: a genotype-phenotype correlation study. Arch Ophthalmol. Apr 2006;124(4):552-7. [Medline].

  64. Wygnanski-Jaffe T, Shin J, Perruzza E, et al. Ophthalmologic findings in the Cornelia de Lange Syndrome. J AAPOS. Oct 2005;9(5):407-15. [Medline].

  65. France NE, Crome L, Abraham JM. Pathological features in the de Lange syndrome. Acta Paediatr Scand. Sep 1969;58(5):470-80. [Medline].

  66. Nechay A, Smulska N, Chepiga L. Anoxic-epileptic seizures in Cornelia de Lange syndrome: case report of epileptic seizures induced by obstructive apnea. Eur J Paediatr Neurol. May 2006;10(3):142-4. [Medline].

  67. Eghlileb AM, Finlay AY. Granulomatous rosacea in Cornelia de Lange syndrome. Indian J Dermatol Venereol Leprol. Jan-Feb 2009;75(1):74-5. [Medline].

  68. [Guideline] Bertrand J, Floyd LL, Weber MK. Guidelines for identifying and referring persons with fetal alcohol syndrome. MMWR Recomm Rep. Oct 28 2005;54:1-14. [Medline].

  69. Gervasini C, Pfundt R, Castronovo P, et al. Search for genomic imbalances in a cohort of 24 Cornelia de Lange patients negative for mutations in the NIPBL and SMC1L1 genes. Clin Genet. Dec 2008;74(6):531-8. [Medline].

  70. Schwartz ID, Schwartz KJ, Kousseff BG, et al. Endocrinopathies in Cornelia de Lange syndrome. J Pediatr. Dec 1990;117(6):920-3. [Medline].

  71. Braddock SR, Lachman RS, Stoppenhagen CC, et al. Radiological features in Brachmann-de Lange syndrome. Am J Med Genet. Nov 15 1993;47(7):1006-13. [Medline].

  72. Kim J, Kim EY, Lee JS, et al. Temporal bone CT findings in Cornelia de Lange syndrome. AJNR Am J Neuroradiol. Mar 2008;29(3):569-73. [Medline].

  73. Vuilleumier N, Kovari E, Michon A, et al. Neuropathological analysis of an adult case of the Cornelia de Lange syndrome. Acta Neuropathol (Berl). Sep 2002;104(3):327-32. [Medline].

  74. FitzPatrick D, Kline AD. Cornelia de Lange syndrome. In: Cassidy SB, Allanson JE. Management of genetic syndromes. 2nd. New York: Wiley-Liss; 2005:139-149.

  75. Kawai M, Kawahara H, Hirayama S, et al. Effect of baclofen on emesis and 24-hour esophageal pH in neurologically impaired children with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. Mar 2004;38(3):317-23. [Medline].

  76. Papadimos TJ, Marco AP. Cornelia de Lange syndrome, hyperthermia and a difficult airway. Anaesthesia. Sep 2003;58(9):924-5. [Medline].

  77. Huang WH, Porto M. Abnormal first-trimester fetal nuchal translucency and Cornelia De Lange syndrome. Obstet Gynecol. May 2002;99(5 Pt 2):956-8. [Medline].

  78. Manouvrier S, Espinasse M, Vaast P, et al. Brachmann-de Lange syndrome: pre- and postnatal findings. Am J Med Genet. Mar 29 1996;62(3):268-73. [Medline].

  79. Urban M, Hartung J. Ultrasonographic and clinical appearance of a 22-week-old fetus with Brachmann-de Lange syndrome. Am J Med Genet. Jul 22 2001;102(1):73-5. [Medline].

  80. Aitken DA, Ireland M, Berry E, et al. Second-trimester pregnancy associated plasma protein-A levels are reduced in Cornelia de Lange syndrome pregnancies. Prenat Diagn. Aug 1999;19(8):706-10. [Medline].

  81. Le Vaillant C, Quere MP, David A, et al. Prenatal diagnosis of a 'minor' form of Brachmann-de Lange syndrome by three-dimensional sonography and three-dimensional computed tomography. Fetal Diagn Ther. Mar-Apr 2004;19(2):155-9. [Medline].

  82. Borck G, Zarhrate M, Cluzeau C, et al. Father-to-daughter transmission of Cornelia de Lange syndrome caused by a mutation in the 5' untranslated region of the NIPBL Gene. Hum Mutat. Aug 2006;27(8):731-5. [Medline].

  83. Brachmann W. Ein fall von symmetrischer monodaktylie durch Ulnadefekt, mit symmetrischer flughautbildung in den ellenbeugen, sowie anderen abnormitaten (zwerghaftogkeit, halsrippen, behaarung). Jarb Kinder Phys Erzie. 1916;84:225-235.

  84. de Lange C. Sur un type nouveau de degenerescence (typus Amstelodamensis). Arch Med Enfants. 1933;36:713-719.

  85. Dorsett D. Roles of the sister chromatid cohesion apparatus in gene expression, development, and human syndromes. Chromosoma. Feb 2007;116(1):1-13. [Medline].

  86. Feingold M, Lin AE. Familial Brachmann-de Lange syndrome: further evidence for autosomal dominant inheritance and review of the literature. Am J Med Genet. Nov 15 1993;47(7):1064-7. [Medline].

  87. Fernandez-Garcia R, Perez Mencia T, Gutierrez-Jodra A, et al. Anesthetic management with laryngeal mask in a child with Brachmann-de Lange syndrome. Paediatr Anaesth. Jun 2006;16(6):698-700. [Medline].

  88. Hyman P, Oliver C, Hall S. Self-injurious behavior, self-restraint, and compulsive behaviors in Cornelia de Lange syndrome. Am J Ment Retard. Mar 2002;107(2):146-54. [Medline].

  89. Ireland M. Cornelia de Lange syndrome: clinical features, common complications and long-term prognosis. Curr Pediatr. 1996;6:69-73.

  90. Ireland M, Donnai D, Burn J. Brachmann-de Lange syndrome. Delineation of the clinical phenotype. Am J Med Genet. Nov 15 1993;47(7):959-64. [Medline].

  91. Krantz ID, Tonkin E, Smith M, et al. Exclusion of linkage to the CDL1 gene region on chromosome 3q26.3 in some familial cases of Cornelia de Lange syndrome. Am J Med Genet. Jun 15 2001;101(2):120-9. [Medline].

  92. Pashayan H, Whelan D, Guttman S, Fraser FC. Variability of the de Lange syndrome: report of 3 cases and genetic analysis of 54 families. J Pediatr. Nov 1969;75(5):853-8. [Medline].

  93. Sataloff RT, Spiegel JR, Hawkshaw M, et al. Cornelia de Lange syndrome. Otolaryngologic manifestations. Arch Otolaryngol Head Neck Surg. Sep 1990;116(9):1044-6. [Medline].

  94. Sekimoto H, Osada H, Kimura H, et al. Prenatal findings in Brachmann-de Lange syndrome. Arch Gynecol Obstet. Apr 2000;263(4):182-4. [Medline].

  95. Selicorni A, Sforzini C, Milani D, et al. Anomalies of the kidney and urinary tract are common in de Lange syndrome. Am J Med Genet A. Feb 1 2005;132(4):395-7. [Medline].

  96. Tonkin ET, Wang TJ, Lisgo S, et al. NIPBL, encoding a homolog of fungal Scc2-type sister chromatid cohesion proteins and fly Nipped-B, is mutated in Cornelia de Lange syndrome. Nat Genet. Jun 2004;36(6):636-41. [Medline].

 
Previous
Next
 
Case study 1 of classic de Lange phenotype is shown (same patient as in Images 2-6). Facial characteristics of a 10-month-old girl are pictured. Note well-defined eyebrows with synophrys, depressed nasal bridge, and long smooth philtrum.
Case study 1 (same patient as in Images 1 and 3-6). Lateral facial profile is pictured. The eyebrows are neat, arched, and well defined. The nasal bridge is depressed, and the nares are upturned.
Case study 1 (same patient as in Images 1-2 and 4-6). The patient, aged 5 years, is shown; note microbrachycephaly, well-defined eyebrows, anteverted nares, long and thin upper lip, down-turned angles of mouth, and widely spaced teeth.
Case study 1 (same patient as in Images 1-3 and 5-6). Upper limb reduction anomalies are pictured with only 2 fingers present.
Case study 1 (same patient as in Images 1-4 and 6). Note short hypoplastic fifth finger.
Case study 1 (same patient as in Images 1-5). Small feet with short hypoplastic toes and syndactyly of the second and third toes is pictured.
Case study 2 of mild de Lange syndrome is shown (same patient as in Images 8-10). The face of a 1.5-year-old girl is pictured. Note neat eyebrows with delicate synophrys, long eyelashes, depressed nasal bridge, upturned nares, long philtrum, thin upper lip, and small chin.
Case study 2 (same patient as in Images 7 and 9-10). Lateral facial profile shows depressed nasal bridge, thin upper lip, and small mandible.
Case study 2 (same patient as in Images 7-8 and 10). The patient, aged 8 years, is shown; note delicate synophrys of the eyebrows, upturned nares, long philtrum, and thin upper lip.
Case study 2 (same patient as in Images 7-9). Lateral facial profile of the patient, aged 8 years, is shown.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.